Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis Larry ZanaApril 19, 2022
Consegna Pharma Receives NIH Research Grant to Develop CP216, a Sustained-Release Naloxone Treatment for Opioid Overdose Reversal Larry ZanaDecember 12, 2019
